LY2109761, 98%, a novel selective TGF-β receptor type I/II (TβRI/II) dual inhibitor - 25MG 25mg
Prod No.CASMDLUnitsPriceQuantity
VL264308-25MG 700874-71-1     
 
 
LY2109761, 98%, a novel selective TGF-β receptor type I/II (TβRI/II) dual inhibitor - 5MG 5mg
Prod No.CASMDLUnitsPriceQuantity
VL264308-5MG 700874-71-1     
 
 
LY2109761
Prod No.CASMDLUnitsPriceQuantity
VL424556 700874-71-1     
 
 
LY2109761 100mg
Prod No.CASMDLUnitsPriceQuantity
VL424556-100mg 700874-71-1  
  VL424556-100mg  LY2109761 100mg 315,00 
 
 
LY2109761 1g
Prod No.CASMDLUnitsPriceQuantity
VL424556-1g 700874-71-1  
  VL424556-1g  LY2109761 1g 1.489,00 
 
 
LY2109761 250mg
Prod No.CASMDLUnitsPriceQuantity
VL424556-250mg 700874-71-1  
  VL424556-250mg  LY2109761 250mg 608,00